Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 96

More Articles from The Primary Care Companion for DNS Disorders

PCC
Article

June 7, 2018

Do visible minority patients have poorer service engagement and follow-up in mental health care in Canada? The objective of this study was to determine whether visible minority patients with…
, ,
PCC
Article

May 31, 2018

Currently, there are no comprehensive guidelines for sedative-hypnotic use in patients with mental illness. Patients taking sedative-hypnotics are more likely to suffer from adverse drug events, including death, compared…
, , , et al
PCC
Rounds in the General Hospital

May 31, 2018

Have you ever wondered whether you could facilitate better collaboration with a patient who appears to reject your help during an acute medical event? Have you ever had trouble…
, ,
PCC
Letter to the Editor

May 31, 2018

Anxiety specialists tend to avoid prescribing stimulants due to potential negative effects; however, their use may be justified in patients who cannot tolerate antidepressants or in those whose ADHD…
,
PCC
Article

May 24, 2018

Significant disparities in quality of health care delivered to individuals with serious mental illness have been reported, possibly due to health care providers’ negative attitudes and low expectations for…
, ,
PCC
Letter to the Editor

May 24, 2018

Modafinil is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder. Modafinil has been found to induce mania…
,
PCC
Letter to the Editor

May 17, 2018

Use of selective serotonin reuptake inhibitors in clinical practice has increased. Early presentation of serotonin syndrome can be vague and easily dismissed. The authors of this report describe a…
,
PCC
Letter to the Editor

May 17, 2018

Benzodiazepine tolerance after multiple days or weeks has been described—but not within 48 hours. Read this report of a man with catatonia who rapidly developed tolerance to lorazepam in…
,
PCC
Article

May 10, 2018

Use of SGAs for the treatment of depression has increased, and patients with depression and comorbid diabetes or cardiovascular disease are more likely to use these therapies than those…
, , , et al
PCC
Letter to the Editor

May 10, 2018

Oseltamivir (Tamiflu) is widely used for the treatment of influenza. However, adverse neuropsychiatric effects, including behavioral changes and perceptional disturbance, have been observed in oseltamivir-treated patients. Here, read about…
, , , et al
PCC
Article

May 3, 2018

Antibiotics have been extensively used by clinicians to treat patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome. In this review, the authors…
,
PCC
Letter to the Editor

May 3, 2018

Hypomanic and manic symptoms are common in the postpartum period and can occur alone or in combination with symptoms of depression. Here, case histories are presented of 2 women…

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe